|
Mesoblast Ltd - Company Profile Snapshot
| Company Profile: |
Mesoblast Ltd |
| Ticker: |
MSB |
| Exchanges: |
MBE |
| 2009 Sales: |
n/a |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Miscellaneous Companies |
| Country: |
AUSTRALIA |
| Employees: |
2 |
Business Description
Mesoblast Ltd. The Group's principal activity is developing biological products in the field of regenerative medicine. It is developing an adult stem cell platform for use in the global orthopedic industry, targeting a range of bone, cartilage and musculoskeletal conditions. The Group has the worldwide exclusive rights for orthopedic indications relating to a series of patents and technologies that have been developed over more than 10 years and which relate to the identification, extraction, and culture of adult Mesenchymal Precursor Cells (MPCs). The Group holds a substantial interest in Angioblast Systems Inc., an American company developing the same platform technology for the treatment of cardiovascular diseases, including repair and regeneration of blood vessels and heart muscle.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
